Trends on Analytical Characterization of Polysorbates and Their Degradation Products in Biopharmaceutical Formulations.

Among many other applications, polysorbates (PSs) are used as the most common surfactants in biopharmaceutical products in particular to protect proteins against interfacial stress. Structural heterogeneity, presence of degradants and other impurities, and tendency for degradation are interrelated features found in commercial PSs with a direct impact on their functional properties in biopharmaceutical products. These pose a challenge for the analytical characterization of PSs at different stages of product development. This review article focuses on methods and strategies reported in the recent years for the analytical characterization of PSs, their degradants and other impurities within neat PS (i.e., PS raw materials), diluted PS solutions, as well as in biopharmaceutical formulations. The use of versatile and complementary methods applied in a systematic approach is crucial to understand the impact of the concentration, composition, and degradation of PSs on the quality of biopharmaceutical products.

[1]  Lori Burton,et al.  Sensitive fluorescence-based method for the rapid determination of polysorbate-80 content in therapeutic monoclonal antibody products , 2015, Pharmaceutical development and technology.

[2]  A. Pappenberger,et al.  Degradation of polysorbates 20 and 80: studies on thermal autoxidation and hydrolysis. , 2011, Journal of pharmaceutical sciences.

[3]  Ankit Patel,et al.  Identification of Subvisible Particles in Biopharmaceutical Formulations Using Raman Spectroscopy Provides Insight into Polysorbate 20 Degradation Pathway , 2015, Pharmaceutical Research.

[4]  John F. Carpenter,et al.  Subvisible and Visible Particle Analysis in Biopharmaceutical Research and Development , 2015 .

[5]  B. Kerwin.  Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. , 2008, Journal of pharmaceutical sciences.

[6]  Y. Kao,et al.  Analysis Methods of Polysorbate 20: A New Method to Assess the Stability of Polysorbate 20 and Established Methods That May Overlook Degraded Polysorbate 20 , 2002, Pharmaceutical Research.

[7]  B. Kerwin,et al.  A Quantitative Kinetic Study of Polysorbate Autoxidation: The Role of Unsaturated Fatty Acid Ester Substituents , 2009, Pharmaceutical Research.

[8]  Riccardo Torosantucci,et al.  Oxidation of Therapeutic Proteins and Peptides: Structural and Biological Consequences , 2014, Pharmaceutical Research.

[9]  Theodore W Randolph,et al.  Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes. , 2015, Journal of pharmaceutical sciences.

[10]  T. Vliet,et al.  Interfacial rheological properties of adsorbed protein layers and surfactants: a review. , 2001, Advances in colloid and interface science.

[11]  Theodore W Randolph,et al.  Protein aggregation and particle formation in prefilled glass syringes. , 2014, Journal of pharmaceutical sciences.

[12]  Theodore W Randolph,et al.  IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: a model for siliconized primary containers. , 2013, Journal of pharmaceutical sciences.

[13]  W. Vaz,et al.  Determination of the critical micelle concentration of surfactants using the fluorescent probe N-phenyl-1-naphthylamine. , 1986, Analytical biochemistry.

[14]  H. K. Khor,et al.  Use of ferric thiocyanate derivatization for quantification of polysorbate 80 in high concentration protein formulations. , 2014, Talanta.

[15]  A. Rosenberg,et al.  Effects of protein aggregates: An immunologic perspective , 2006, The AAPS Journal.

[16]  Gregory A. Sacha,et al.  Pre-filled syringes: a review of the history, manufacturing and challenges , 2015, Pharmaceutical development and technology.

[17]  C. Tribet,et al.  Importance of the dynamics of adsorption and of a transient interfacial stress on the formation of aggregates of IgG antibodies , 2012 .

[18]  Hui Xu,et al.  Evaluation of hydroperoxides in common pharmaceutical excipients. , 2007, Journal of pharmaceutical sciences.

[19]  Theodore W Randolph,et al.  Excipient effects on humanized monoclonal antibody interactions with silicone oil emulsions. , 2012, Journal of pharmaceutical sciences.

[20]  Hanns-Christian Mahler,et al.  The Degradation of Polysorbates 20 and 80 and its Potential Impact on the Stability of Biotherapeutics , 2011, Pharmaceutical Research.

[21]  R. Zhang,et al.  Analysis of polysorbate 80 and its related compounds by RP-HPLC with ELSD and MS detection. , 2012, Journal of chromatographic science.

[22]  Alavattam Sreedhara,et al.  Hexyl glucoside and hexyl maltoside inhibit light-induced oxidation of tryptophan. , 2014, Journal of pharmaceutical sciences.

[23]  Sandeep Yadav,et al.  Polysorbate 20 Degradation in Biopharmaceutical Formulations: Quantification of Free Fatty Acids, Characterization of Particulates, and Insights into the Degradation Mechanism. , 2015, Molecular pharmaceutics.

[24]  A. Gray,et al.  Composition analysis of two batches of polysorbate 60 using MS and NMR techniques. , 2006, Journal of pharmaceutical and biomedical analysis.

[25]  U. Holzgrabe,et al.  Fatty acid composition analysis in polysorbate 80 with high performance liquid chromatography coupled to charged aerosol detection. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  S. Wolff,et al.  Peroxide accumulation in detergents. , 1994, Journal of biochemical and biophysical methods.

[27]  J. Ji,et al.  Mixed-mode and reversed-phase liquid chromatography-tandem mass spectrometry methodologies to study composition and base hydrolysis of polysorbate 20 and 80. , 2011, Journal of chromatography. A.

[28]  Wei Wang,et al.  Peroxide formation in polysorbate 80 and protein stability. , 2002, Journal of pharmaceutical sciences.

[29]  Yi Li,et al.  Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry. , 2014, Analytical chemistry.

[30]  Yang Meng,et al.  NMR method for accurate quantification of polysorbate 80 copolymer composition. , 2015, Analytical chemistry.

[31]  Steven Kozlowski,et al.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. , 2009, Journal of pharmaceutical sciences.

[32]  P. Sporns,et al.  Investigating the molecular heterogeneity of polysorbate emulsifiers by MALDI-TOF MS. , 2001, Journal of agricultural and food chemistry.

[33]  J L Cleland,et al.  Tween protects recombinant human growth hormone against agitation-induced damage via hydrophobic interactions. , 1998, Journal of pharmaceutical sciences.

[34]  R. Reed,et al.  Polysorbate 80 UV/vis spectral and chromatographic characteristics--defining boundary conditions for use of the surfactant in dissolution analysis. , 2006, Journal of pharmaceutical and biomedical analysis.

[35]  K. Dyrstad,et al.  Characterization of polysorbate 80 with liquid chromatography mass spectrometry and nuclear magnetic resonance spectroscopy: specific determination of oxidation products of thermally oxidized polysorbate 80. , 2012, Journal of pharmaceutical and biomedical analysis.

[36]  M. Donbrow,et al.  Autoxidation of polysorbates. , 1978, Journal of pharmaceutical sciences.

[37]  Y. J. Wang,et al.  Hydrolysis of Polysorbate 20 and 80 by a Range of Carboxylester Hydrolases , 2016, PDA Journal of Pharmaceutical Science and Technology.

[38]  T. Patapoff,et al.  Single step method for the accurate concentration determination of polysorbate 80 , 1997 .

[39]  J. Brandner.  The composition of NF-defined emulsifiers: sorbitan monolaurate, monopalmitate, monostearate, monooleate, polysorbate 20, polysorbate 40, polysorbate 60, and polysorbate 80. , 1998, Drug development and industrial pharmacy.

[40]  Wim Jiskoot,et al.  Particles in therapeutic protein formulations, Part 1: overview of analytical methods. , 2012, Journal of pharmaceutical sciences.

[41]  Hanns-Christian Mahler,et al.  Key interactions of surfactants in therapeutic protein formulations: A review. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[42]  Y. J. Wang,et al.  Toward understanding molecular heterogeneity of polysorbates by application of liquid chromatography-mass spectrometry with computer-aided data analysis. , 2011, Analytical chemistry.

[43]  Yang Meng,et al.  Quantitative analysis of polysorbates 20 and 40 by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2013, Rapid Communications in Mass Spectrometry.

[44]  Y. Kao,et al.  The effects of membrane filters used in biopharmaceutical processes on the concentration and composition of polysorbate 20 , 2013, Biotechnology progress.

[45]  T. Kinoshita,et al.  1-Pyrenyldiazomethane as a fluorescent labeling reagent for liquid chromatographic determination of carboxylic acids. , 1988, Analytical chemistry.

[46]  Hanns‐Christian Mahler,et al.  Behaviour of polysorbate 20 during dialysis, concentration and filtration using membrane separation techniques. , 2008, Journal of pharmaceutical sciences.

[47]  A. Blume,et al.  A thermodynamic analysis of the binding interaction between polysorbate 20 and 80 with human serum albumins and immunoglobulins: a contribution to understand colloidal protein stabilisation. , 2009, Biophysical chemistry.

[48]  Zai-Qing Wen,et al.  Raman spectroscopy of protein pharmaceuticals. , 2007, Journal of pharmaceutical sciences.

[49]  J. Casas-Finet,et al.  Universal method for the determination of nonionic surfactant content in the presence of protein , 2015, Journal of separation science.

[50]  J. Fekete,et al.  Fast and sensitive determination of Polysorbate 80 in solutions containing proteins. , 2010, Journal of pharmaceutical and biomedical analysis.

[51]  F. Ayorinde,et al.  Analysis of some commercial polysorbate formulations using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.

[52]  L. Nair,et al.  Determination of polysorbate 80 in parenteral formulations by high-performance liquid chromatography and evaporative light scattering detection. , 2003, Journal of chromatography. A.

[53]  D. Volkin,et al.  Development of a microflow digital imaging assay to characterize protein particulates during storage of a high concentration IgG1 monoclonal antibody formulation. , 2010, Journal of pharmaceutical sciences.

[54]  Reb J. Russell,et al.  Evaporative light scattering detection based HPLC method for the determination of polysorbate 80 in therapeutic protein formulations. , 2012, Journal of chromatographic science.

[55]  Aleš Obreza,et al.  Review of operating principle and applications of the charged aerosol detector. , 2010, Journal of chromatography. A.

[56]  Sandeep Yadav,et al.  Understanding Particle Formation: Solubility of Free Fatty Acids as Polysorbate 20 Degradation Byproducts in Therapeutic Monoclonal Antibody Formulations. , 2015, Molecular pharmaceutics.

[57]  Lihua Huang,et al.  Polysorbates 20 and 80 Degradation by Group XV Lysosomal Phospholipase A2 Isomer X1 in Monoclonal Antibody Formulations. , 2016, Journal of pharmaceutical sciences.

[58]  Shohei Horiuchi,et al.  CMC determination of nonionic surfactants in protein formulations using ultrasonic resonance technology. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[59]  Theodore W Randolph,et al.  Protein adsorption and excipient effects on kinetic stability of silicone oil emulsions. , 2010, Journal of pharmaceutical sciences.

[60]  Jinshu Qiu,et al.  Quantitation of low concentrations of polysorbates in high protein concentration formulations by solid phase extraction and cobalt-thiocyanate derivatization. , 2014, Analytica chimica acta.

[61]  Stijn H S Koshari,et al.  Impact of mono‐ and poly‐ester fractions on polysorbate quantitation using mixed‐mode HPLC‐CAD/ELSD and the fluorescence micelle assay , 2017, Journal of pharmaceutical and biomedical analysis.

[62]  Y. J. Wang,et al.  Oxidative degradation of polysorbate surfactants studied by liquid chromatography-mass spectrometry. , 2015, Journal of pharmaceutical sciences.

[63]  Y. J. Wang,et al.  Degradation Mechanisms of Polysorbate 20 Differentiated by 18O-labeling and Mass Spectrometry , 2016, Pharmaceutical Research.

[64]  Davy Sinnaeve,et al.  Quantification of hydrophilic ethoxylates in polysorbate surfactants using diffusion H1 NMR spectroscopy. , 2010, Journal of pharmaceutical and biomedical analysis.

[65]  A. Hawe,et al.  Formulation Development for Hydrophobic Therapeutic Proteins , 2007, Pharmaceutical development and technology.

[66]  Katherine D Taylor,et al.  Residual Host Cell Protein Promotes Polysorbate 20 Degradation in a Sulfatase Drug Product Leading to Free Fatty Acid Particles. , 2016, Journal of pharmaceutical sciences.

[67]  K. J. Mysels,et al.  Critical Micelle Concentrations of Aqueous Surfactant Systems , 2018 .

[68]  T. R. Bates,et al.  Kinetics of hydrolysis of polyoxyethylene (20) sorbitan fatty acid ester surfactants , 1973, The Journal of pharmacy and pharmacology.

[69]  John Devincentis,et al.  A simple reversed phase high-performance liquid chromatography method for polysorbate 80 quantitation in monoclonal antibody drug products. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[70]  Hanns-Christian Mahler,et al.  Surface activity of a monoclonal antibody. , 2009, Journal of pharmaceutical sciences.

[71]  R T Borchardt,et al.  Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. , 1995, Biotechnology and bioengineering.

[72]  Y. Kao,et al.  Quantitation of polysorbate 20 in protein solutions using mixed-mode chromatography and evaporative light scattering detection. , 2008, Journal of chromatography. A.

[73]  Steven R Labrenz,et al.  Ester hydrolysis of polysorbate 80 in mAb drug product: evidence in support of the hypothesized risk after the observation of visible particulate in mAb formulations. , 2014, Journal of pharmaceutical sciences.

[74]  Jennifer R Litowski,et al.  Free fatty acid particles in protein formulations, part 2: contribution of polysorbate raw material. , 2015, Journal of pharmaceutical sciences.

[75]  Zai-Qing Wen,et al.  Free fatty acid particles in protein formulations, part 1: microspectroscopic identification. , 2015, Journal of pharmaceutical sciences.